StoneX Group
ONCY icon

StoneX Group’s Oncolytics Biotech ONCY Stock Holding History

StoneX Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.4K Buy
+24,397
New +$19.8K ﹤0.01% 1752

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Doliver Advisors
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
Badgley Phelps Wealth Managers
Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Professional Advisory Services
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

StoneX Group's ONCY Position: Q3 2026 in Review

StoneX Group opened a new position in Oncolytics Biotech (ONCY) in Q3 2026: 24,397 shares worth $20.4K. The stake represents ﹤0.01% of the portfolio and ranks #1752 among its holdings.

24 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • StoneX Group held 24,397 shares of Oncolytics Biotech worth $20.4K as of Q3 2026.
  • Oncolytics Biotech was a new StoneX Group position in Q3 2026.
  • Oncolytics Biotech made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1752 holding.
  • 24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.